Why I am challenging NIH ivermectin secrecy in federal court

Why I am challenging NIH ivermectin secrecy in federal court

Note that views expressed in this opinion article are the writer’s personal views and not necessarily those of TrialSite.

The National Institutes of Health (NIH) updated its COVID-19 Treatment Guidelines recommendation for the use of ivermectin in COVID-19 on January 14, 2021. In that update, the NIH removed its recommendation against the use of ivermectin but stated:

“There are insufficient data for the COVID-19 Treatment Guidelines Panel (the Panel) to recommend either for or against the use of ivermectin for the treatment of COVID-19”

The Guidelines also state:

“All recommendations included in the Guidelines are endorsed by a majority of Panel members…”

However, the NIH refused to respond when asked if a vote was held on the ivermectin recommendation. Refusal of the NIH to respond to that question was reported earlier. They refused to respond to both an informal request and to a Freedom of Information Act (FOIA) request. Responding to FOIA requests is required and I filed a complaint on that basis on March 16 in the federal district court in the District of New Jersey. The complaint was filed pro se by email as allowed by t...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

Personal
$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
Professional
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee